NEW YORK Michael Pearson, the former chief executive officer of Valeant Pharmaceuticals International (VRX.TO), has signed a consulting agreement with the drugmaker that will run through 2017 and pay him hundreds of thousands of dollars, according to the separation agreement filed with regulators.
Pearson, who left Valeant on May 2 after a year in which it had drawn scrutiny for its sharp drug price increases, financial relationship with a specialty pharmacy and accounting practices, can earn $83,333 a month this year as a consultant.
06:26 Larry Fitzgerald, Eli Manning, Greg Olsen are Man of Year finalists18
23:04 Fitzgerald, Manning, Olsen are NFL Man of Year finalists11
20:58 Microsoft kills Cache, its note-taking experiment with Evernote-Google Keep aspirations22
14:43 Europe’s nationalist leaders kick off year of election hopes14